Skip to main content

Table 3 Nomenclature of SARS-CoV-2 variants

From: SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression

Nomenclature

Origin

Date

Major variant

WHO

Pango

GISIAD

Nextstrain

Alpha

B.1.1.7

GR/501Y.V1(GRY)

20I/S:501Y.V1

UK

18/12/2020

VOC

9/3/2022

Beta

B.1.351

B.1.351.2

B.1.351.3

GH/501Y.V2

20 H/S:501Y.V2

South Africa

18/12/2020

9/3/2022

Gamma

P.1

P.1.1

P.1.2

P.1.4

P.1.6

P.1.7

GR/501Y.V3

20 J/S:501Y.V3

Brazil

11/1/2021

9/3/2022

Delta

B.1.617.2

AY.1

AY.2

AY.3

AY.3.1

G/452R.V3

21 A/S:478 K

India

11/5/2021

7/6/2022

Omicron parent lineage

B.1.1.529

GR/484A

21 K

Multiple countries

26/11/21

14/3/2023

Epsilon

B.1.427/B.1.429

GH/452R.V1

20 C/S:452R

USA

5/3/2021

VOI

6/7/2021

Zeta

P.2

GR

20B/S:484 K

Brazil

17/3/2021

6/7/2021

Eta

B.1.525

G/484K.V3

21D/S:484 K

Several countries

17/3/2021

20/9/2021

Theta

P.3

GR

20B/S:265 C

Philippines

24/3/2021

6/7/2021

Iota

B.1.526

GH/452R.V1

21 F/S:484 K

USA

24/3/2021

20/9/2021

Kappa

B.1.617.1

G/452R.V3

21B/S:154 K

India

4/4/2021

20/9/2021

Lambda

C.37

GR/452Q.V1

21G

Peru

14/6/2021

Mu

B.1.621

GH

21 H

Colombia

30/8/2021

9/3/2022